# Open Text Corp: financial statements, quarterly

OTEX · Nasdaq · CIK 1002638 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/otex.md) · [Financials](/companies/otex/financials.md) · [Filings](/companies/otex/filings.md) · [Insiders](/companies/otex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/otex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,425](/filings/0001002638-24-000075.md) | [1,535](/filings/0001002638-25-000021.md) | [1,447](/filings/0001002638-25-000040.md) | [1,362 d](/filings/0001002638-26-000068.md) | [1,269](/filings/0001002638-25-000096.md) | [1,335](/filings/0001002638-26-000021.md) | [1,254](/filings/0001002638-26-000046.md) | [1,311 d](/filings/0001002638-26-000068.md) | [1,288](/filings/0001002638-25-000096.md) | [1,327](/filings/0001002638-26-000021.md) | [1,283](/filings/0001002638-26-000046.md) | [1,349 d](/filings/0001002638-26-000068.md) |
| Cost of revenue | $m | [407](/filings/0001002638-24-000075.md) | [406](/filings/0001002638-25-000021.md) | [391](/filings/0001002638-25-000040.md) | [374 d](/filings/0001002638-26-000068.md) | [359](/filings/0001002638-25-000096.md) | [357](/filings/0001002638-26-000021.md) | [356](/filings/0001002638-26-000046.md) | [363 d](/filings/0001002638-26-000068.md) | [351](/filings/0001002638-25-000096.md) | [345](/filings/0001002638-26-000021.md) | [345](/filings/0001002638-26-000046.md) | [338 d](/filings/0001002638-26-000068.md) |
| Gross profit | $m | [1,018](/filings/0001002638-24-000075.md) | [1,129](/filings/0001002638-25-000021.md) | [1,056](/filings/0001002638-25-000040.md) | [988 d](/filings/0001002638-26-000068.md) | [910](/filings/0001002638-25-000096.md) | [978](/filings/0001002638-26-000021.md) | [898](/filings/0001002638-26-000046.md) | [948 d](/filings/0001002638-26-000068.md) | [938](/filings/0001002638-25-000096.md) | [982](/filings/0001002638-26-000021.md) | [937](/filings/0001002638-26-000046.md) | [1,011 d](/filings/0001002638-26-000068.md) |
| Operating income | $m | [213](/filings/0001002638-24-000075.md) | [254](/filings/0001002638-25-000021.md) | [227](/filings/0001002638-25-000040.md) | [193 d](/filings/0001002638-26-000068.md) | [206](/filings/0001002638-25-000096.md) | [296](/filings/0001002638-26-000021.md) | [209](/filings/0001002638-26-000046.md) | [182 d](/filings/0001002638-26-000068.md) | [270](/filings/0001002638-25-000096.md) | [292](/filings/0001002638-26-000021.md) | [201](/filings/0001002638-26-000046.md) | [320 d](/filings/0001002638-26-000068.md) |
| Income tax | $m | [10.4](/filings/0001002638-24-000075.md) | [8.1](/filings/0001002638-25-000021.md) | [6.0](/filings/0001002638-25-000040.md) | [240 d](/filings/0001002638-26-000068.md) | [1.9](/filings/0001002638-25-000096.md) | [50.9](/filings/0001002638-26-000021.md) | [10.8](/filings/0001002638-26-000046.md) | [(17.6) d](/filings/0001002638-26-000068.md) | [39.2](/filings/0001002638-25-000096.md) | [47.3](/filings/0001002638-26-000021.md) | [34.3](/filings/0001002638-26-000046.md) | [94.8 d](/filings/0001002638-26-000068.md) |
| Net income | $m | [80.9](/filings/0001002638-24-000075.md) | [37.7](/filings/0001002638-25-000021.md) | [98.3](/filings/0001002638-25-000040.md) | [248 d](/filings/0001002638-26-000068.md) | [84.4](/filings/0001002638-25-000096.md) | [230](/filings/0001002638-26-000021.md) | [92.8](/filings/0001002638-26-000046.md) | [28.8 d](/filings/0001002638-26-000068.md) | [147](/filings/0001002638-25-000096.md) | [168](/filings/0001002638-26-000021.md) | [173](/filings/0001002638-26-000046.md) | [156 d](/filings/0001002638-26-000068.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001002638-24-000075.md) | [0.14](/filings/0001002638-25-000021.md) | [0.36](/filings/0001002638-25-000040.md) | not reported | [0.32](/filings/0001002638-25-000096.md) | [0.87](/filings/0001002638-26-000021.md) | [0.35](/filings/0001002638-26-000046.md) | not reported | [0.58](/filings/0001002638-25-000096.md) | [0.66](/filings/0001002638-26-000021.md) | [0.70](/filings/0001002638-26-000046.md) | not reported |
| Basic EPS | $ per share | [0.30](/filings/0001002638-24-000075.md) | [0.14](/filings/0001002638-25-000021.md) | [0.36](/filings/0001002638-25-000040.md) | not reported | [0.32](/filings/0001002638-25-000096.md) | [0.87](/filings/0001002638-26-000021.md) | [0.35](/filings/0001002638-26-000046.md) | not reported | [0.58](/filings/0001002638-25-000096.md) | [0.67](/filings/0001002638-26-000021.md) | [0.70](/filings/0001002638-26-000046.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0001002638-24-000075.md) | [1.0](/filings/0001002638-25-000021.md) | [1.1](/filings/0001002638-25-000040.md) | [1.3](/filings/0001002638-26-000068.md) | [1.0](/filings/0001002638-25-000096.md) | [1.1](/filings/0001002638-26-000021.md) | [1.3](/filings/0001002638-26-000046.md) | [1.2](/filings/0001002638-26-000068.md) | [1.1](/filings/0001002638-25-000096.md) | [1.3](/filings/0001002638-26-000021.md) | [1.3](/filings/0001002638-26-000046.md) | [1.0](/filings/0001002638-26-000068.md) |
| Current assets | $bn | [1.9](/filings/0001002638-23-000032.md) | [4.1](/filings/0001002638-24-000005.md) | [4.2](/filings/0001002638-24-000025.md) | [2.3](/filings/0001002638-25-000053.md) | [2.0](/filings/0001002638-24-000075.md) | [2.1](/filings/0001002638-25-000021.md) | [2.2](/filings/0001002638-25-000040.md) | [2.2](/filings/0001002638-26-000068.md) | [2.1](/filings/0001002638-25-000096.md) | [2.4](/filings/0001002638-26-000021.md) | [2.4](/filings/0001002638-26-000046.md) | [2.1](/filings/0001002638-26-000068.md) |
| Total assets | $bn | [16.6](/filings/0001002638-23-000032.md) | [16.4](/filings/0001002638-24-000005.md) | [16.4](/filings/0001002638-24-000025.md) | [14.2](/filings/0001002638-25-000053.md) | [13.8](/filings/0001002638-24-000075.md) | [13.7](/filings/0001002638-25-000021.md) | [13.8](/filings/0001002638-25-000040.md) | [13.8](/filings/0001002638-26-000068.md) | [13.5](/filings/0001002638-25-000096.md) | [13.6](/filings/0001002638-26-000021.md) | [13.3](/filings/0001002638-26-000046.md) | [13.1](/filings/0001002638-26-000068.md) |
| Current liabilities | $bn | [2.8](/filings/0001002638-23-000032.md) | [3.0](/filings/0001002638-24-000005.md) | [3.0](/filings/0001002638-24-000025.md) | [2.8](/filings/0001002638-25-000053.md) | [2.5](/filings/0001002638-24-000075.md) | [2.4](/filings/0001002638-25-000021.md) | [2.5](/filings/0001002638-25-000040.md) | [2.7](/filings/0001002638-26-000068.md) | [2.5](/filings/0001002638-25-000096.md) | [2.5](/filings/0001002638-26-000021.md) | [2.5](/filings/0001002638-26-000046.md) | [2.6](/filings/0001002638-26-000068.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | [8.6](/filings/0001002638-23-000032.md) | [8.5](/filings/0001002638-24-000005.md) | [8.3](/filings/0001002638-24-000025.md) | [6.4](/filings/0001002638-25-000053.md) | [6.4](/filings/0001002638-24-000075.md) | [6.3](/filings/0001002638-25-000021.md) | [6.3](/filings/0001002638-25-000040.md) | [6.3](/filings/0001002638-26-000068.md) | [6.3](/filings/0001002638-25-000096.md) | [6.3](/filings/0001002638-26-000021.md) | [6.2](/filings/0001002638-26-000046.md) | [5.7](/filings/0001002638-26-000068.md) |
| Current portion of debt | $bn | [0.1](/filings/0001002638-23-000032.md) | [0.0](/filings/0001002638-24-000005.md) | [0.0](/filings/0001002638-24-000025.md) | [0.0](/filings/0001002638-25-000053.md) | [0.0](/filings/0001002638-24-000075.md) | [0.0](/filings/0001002638-25-000021.md) | [0.0](/filings/0001002638-25-000040.md) | [0.0](/filings/0001002638-26-000068.md) | [0.0](/filings/0001002638-25-000096.md) | [0.0](/filings/0001002638-26-000021.md) | [0.0](/filings/0001002638-26-000046.md) | [0.0](/filings/0001002638-26-000068.md) |
| Shareholders' equity | $bn | [4.0](/filings/0001002638-23-000032.md) | [4.0](/filings/0001002638-24-000005.md) | [4.1](/filings/0001002638-24-000025.md) | [4.2](/filings/0001002638-25-000053.md) | [4.1](/filings/0001002638-24-000075.md) | [4.2](/filings/0001002638-25-000021.md) | [4.1](/filings/0001002638-25-000040.md) | [3.9](/filings/0001002638-26-000068.md) | [4.0](/filings/0001002638-25-000096.md) | [4.0](/filings/0001002638-26-000021.md) | [4.0](/filings/0001002638-26-000046.md) | [4.0](/filings/0001002638-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.1](/filings/0001002638-24-000075.md) | [351 d](/filings/0001002638-25-000021.md) | [385 d](/filings/0001002638-25-000040.md) | [185 d](/filings/0001002638-26-000068.md) | [(77.8)](/filings/0001002638-25-000096.md) | [348 d](/filings/0001002638-26-000021.md) | [402 d](/filings/0001002638-26-000046.md) | [158 d](/filings/0001002638-26-000068.md) | [148](/filings/0001002638-25-000096.md) | [319 d](/filings/0001002638-26-000021.md) | [355 d](/filings/0001002638-26-000046.md) | [186 d](/filings/0001002638-26-000068.md) |
| Capital expenditure | $m | [37.5](/filings/0001002638-24-000075.md) | [45.2 d](/filings/0001002638-25-000021.md) | [36.5 d](/filings/0001002638-25-000040.md) | [40.0 d](/filings/0001002638-26-000068.md) | [39.3](/filings/0001002638-25-000096.md) | [41.3 d](/filings/0001002638-26-000021.md) | [28.4 d](/filings/0001002638-26-000046.md) | [34.2 d](/filings/0001002638-26-000068.md) | [46.5](/filings/0001002638-25-000096.md) | [39.2 d](/filings/0001002638-26-000021.md) | [49.7 d](/filings/0001002638-26-000046.md) | [63.8 d](/filings/0001002638-26-000068.md) |
| Dividends paid | $m | [67.0](/filings/0001002638-24-000075.md) | [66.4](/filings/0001002638-25-000021.md) | [67.3](/filings/0001002638-25-000040.md) | [66.7 d](/filings/0001002638-26-000068.md) | [69.1](/filings/0001002638-25-000096.md) | [68.3](/filings/0001002638-26-000021.md) | [67.9](/filings/0001002638-26-000046.md) | [66.2 d](/filings/0001002638-26-000068.md) | [68.2](/filings/0001002638-25-000096.md) | [68.5](/filings/0001002638-26-000021.md) | [66.3](/filings/0001002638-26-000046.md) | [65.4 d](/filings/0001002638-26-000068.md) |
| Share repurchases | $m | [0.0](/filings/0001002638-24-000075.md) | [0.0 d](/filings/0001002638-25-000021.md) | [0.0 d](/filings/0001002638-25-000040.md) | [150 d](/filings/0001002638-26-000068.md) | [87.4](/filings/0001002638-25-000096.md) | [66.0 d](/filings/0001002638-26-000021.md) | [115 d](/filings/0001002638-26-000046.md) | [145 d](/filings/0001002638-26-000068.md) | [108](/filings/0001002638-25-000096.md) | [50.0 d](/filings/0001002638-26-000021.md) | [247 d](/filings/0001002638-26-000046.md) | [11.8 d](/filings/0001002638-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [270](/filings/0001002638-23-000032.md) | [270](/filings/0001002638-24-000005.md) | [271](/filings/0001002638-24-000025.md) | [272](/filings/0001002638-24-000075.md) | [272](/filings/0001002638-25-000021.md) | [273](/filings/0001002638-25-000040.md) | [268](/filings/0001002638-25-000096.md) | [265](/filings/0001002638-26-000021.md) | [264](/filings/0001002638-26-000046.md) | [254](/filings/0001002638-25-000096.md) | [254](/filings/0001002638-26-000021.md) | [248](/filings/0001002638-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 242,126,739 at 2026-07-31, from the cover of the [10-K filed 2026-08-06](/filings/0001002638-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.